ATC Group: C09XA52 Aliskiren and hydrochlorothiazide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C09XA52 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C09 Agents acting on the renin-angiotensin system
3 C09X Other agents acting on the renin-angiotensin system
4 C09XA Renin-inhibitors
5 C09XA52 Aliskiren and hydrochlorothiazide

Active ingredients in C09XA52

Active Ingredient

Combination of two antihypertensive active substances to control blood pressure in patients with essential hypertension. Aliskiren belongs to the class of direct renin inhibitors and hydrochlorothiazide to the class of thiazide diuretics. The combination of these substances with complementary mechanisms of action provides an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

Related product monographs

Document Type Information Source  
 RASILEZ HCT Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicines in this ATC group

Austria (AT)

Cyprus (CY)

Estonia (EE)

Hong Kong (HK)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.